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Abstract
Background: Predicting postoperative lung function is important for estimating the risk of complications and
long-term disability after pulmonary resection. We investigated the capability of vibration response imaging (VRI) as
an alternative to lung scintigraphy for prediction of postoperative lung function in patients with intrathoracic
malignancies.
Methods: Eighty-five patients with intrathoracic malignancies, considered candidates for lung resection, were
prospectively studied. The projected postoperative (ppo) lung function was calculated using: perfusion scintigraphy,
ventilation scintigraphy, and VRI. Two sets of assessments made: one for lobectomy and one for pneumonectomy.
Clinical concordance was defined as both methods agreeing that either a patient was or was not a surgical
candidate based on a ppoFEV1% and ppoDLCO% > 40%.
Results: Limits of agreement between scintigraphy and VRI for ppo following lobectomy were -16.47% to 15.08%
(mean difference = -0.70%;95%CI = -2.51% to 1.12%) and for pneumonectomy were -23.79% to 19.04% (mean
difference = -2.38%;95%CI = -4.69% to -0.07%). Clinical concordance between VRI and scintigraphy was 73% for
pneumonectomy and 98% for lobectomy. For patients who had surgery and postoperative lung function testing
(n = 31), ppoFEV1% using scintigraphic methods correlated with measured postoperative values better than
projections using VRI, (adjusted R2 = 0.32 scintigraphy; 0.20 VRI), however the difference between methods failed to
reach statistical significance. Limits of agreement between measured FEV1% postoperatively and ppoFEV1% based
on perfusion scintigraphy were -16.86% to 23.73% (mean difference = 3.44%;95%CI = -0.29% to 7.16%); based on
VRI were -19.56% to 28.99% (mean difference = 4.72%;95%CI = 0.27% to 9.17%).
Conclusions: Further investigation of VRI as an alternative to lung scintigraphy for prediction of postoperative lung
function is warranted.
Background
Surgical lung resection remains the best option for cure
of early stage non-small cell lung cancer and is the main-
stay for treatment of other intrathoracic malignancies [1].
In assessing operability of patients with resectable lung
malignancies, it is essential to define both the immediate
perioperative risk and the long-term risk of pulmonary
disability associated with loss of functional lung [1]. For
patients with abnormalities on initial pulmonary function
evaluation, quantitative radionuclide ventilation and per-
fusion studies are commonly used to evaluate split lung
function and have been demonstrated to accurately
predict postoperative lung function and outcome [2-5].
A projected postoperative FEV1 (ppoFEV1%) < 40% of
predicted or a projected postoperative DLCO (ppoDLCO
%) < 40% indicates an increased risk for perioperative
death and cardiopulmonary complications with standard
lung resection [5]. In a search for simpler alternatives to
radionuclide tests for estimation of postoperative lung
function, we studied quantitative measurements of acous-
tic vibratory energy at the chest wall generated by breath
sounds during spontaneous breathing using a vibratory
response imaging system (VRI).
In this pilot study, our primary objective was to assess
the agreement of ppoFEV1% and ppoDLCO% as deter-
mined by VRI, perfusion, and ventilation scintigraphy. Our
secondary objective was to obtain exploratory data
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comparing actual postoperative FEV1 values with ppo-
FEV1% values as determined by VRI or lung scintigraphy.
Methods
Study Population and Design
We prospectively studied patients with lung cancer or
other intrathoracic malignancies, considered candidates
for lung resection, who were referred to estimate post-
operative lung function. The patients gave informed
written consent to participate in the study. The protocol
was approved by the Institutional Review Board of The
University of Texas M.D. Anderson Cancer Center. All
patients underwent lung function, radionuclide perfu-
sion and ventilation scintigraphy, and VRI testing on the
same day.
Lung Function Testing
Pulmonary function tests were obtained according to
published guidelines [6] utilizing a Pulmonary Function
Laboratory 2400 System (SensorMedics; Anaheim, CA).
Postoperative lung function was measured at 4-8 weeks
after surgery with the same equipment.
Radionuclide Perfusion and Ventilation Scintigraphy for
Determining Regional Pulmonary Function
Radionuclide lung studies were performed using a mul-
tidetector system (Canberra Industries; Meriden, CT)
according to the method described by Ali et al [7]. We
considered the upper half of the tumor-bearing lung
measurements to represent the functional loss after
upper lobectomy, the lower half the functional loss for
lower lobectomy (including the middle lobe on the right
hemithorax), and the entire lung for pneumonectomy
procedures.
VRI for Determining Regional Pulmonary Function
Patients were tested using a VRIXP(tm) device (Deep
Breeze(tm), Or-Akiva, Israel). Vibrations of the lungs
were captured during inspiration and expiration via the
mouth for 12 seconds by two arrays of seven or six
piezoelectric sensors attached to the posterior chest by
low vacuum (Figure 1). Signals were filtered, amplified,
and converted into digital data for regional quantitative
analysis based on location of each sensor [8,9]. Record-
ings with artifacts were excluded and two satisfactory
recordings per patient were obtained. With the excep-
tion of recordings with artifacts, the second recording
was always selected for analysis.
Similar to lung scintigraphy, vibrations originating from
upper half of sensors in the tumor-bearing hemithorax
represented the functional loss after upper lobectomy, the
lower half the functional loss for lower lobectomy, and the
entire sensor array for pneumonectomy procedures. An
adjustment was made in which 5% of the total vibration
energy on the left side was shifted to the right side (2% to
the upper lung region and 3% to the lower) in order to
compensate for greater lung sound distribution in the left
lung as reported in the literature [10,11].
Prediction of Postoperative Lung Function
Formulas for prediction of postoperative lung function
were the same for VRI, ventilation, or perfusion, as fol-
lows [12]:
(1) ppoFEV1% (VRI, perfusion, or ventilation) =
FEV1pre-op percent of predicted*(100%-projected per-
centage loss of lung function).
(2) ppoDLCO% (VRI, perfusion, or ventilation) =
DLCOpre-op percent of predicted*(100%-projected
percentage loss of lung function).
Statistical Analysis
For the primary analysis, VRI was compared to perfu-
sion scintigraphy. A separate analysis was performed
comparing VRI with ventilation scintigraphy.
Figure 1 Vibration response imaging system: the energy
generated by the vibrations of the lungs during inspiration
and expiration is discerned by two arrays of piezoelectric
sensors during 12 seconds of recording. Written informed
consent was obtained from the patient for publication of the
accompanying image.
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We used mean and standard deviation to describe
continuous variables distributed normally. We used
medians and interquartile ranges (25%-75%) for non-
normally distributed data. We used paired T-tests to
compare groups for normally distributed data and the
Wilcoxon signed-rank test for non-normally distributed
data. We assessed agreement between methods of deter-
mining projected percentage loss of lung function using
a variety of methods. Our primary method was the
Bland-Altman method [13]. We used Pittman’s test of
difference to evaluate correlation between differences
between measures and the mean of the measures when
performing Bland-Altman analysis [14].
We also performed simple and multivariable linear
regression and used Pearson correlation coefficients to
evaluate the strength of relationships between variables.
For each test-VRI, perfusion, and ventilation - we used
the following method to assess the ability of the test to
explain the variability among the actual observed out-
comes. The outcome we used was actual measured post-
operative FEV1%. First, we assessed the relationship of
baseline preoperative FEV1% with postoperative FEV1%
using linear regression. Second, we assessed the relation-
ship of residual functional lung as predicted by the test-
ing method with postoperative FEV1% using linear
regression. Residual functional lung was represented by
the formula (100%-projected percentage loss of lung
function). Third, we constructed a multivariable model
consisting of baseline FEV1%, residual functional lung,
and a variable representing the interaction of these two
variables. Our fourth model used just the interaction
variable. Note that this is what is used in standard clini-
cal practice. We compared models using adjusted R2
values. We used the methods of Cohen and Cohen to
compare correlation coefficients from simple linear
regression to determine which test was better at explain-
ing the variance in measured postoperative FEV1 [15].
We then performed the same analysis for the outcome
of actual measured postoperative DLCO%. We also gra-
phically analyzed regression results compared to the line
of unity.
Results
Ninety-nine patients (54 males and 45 females; age 65 ±
8 years, range 46-83 years) with: non-small cell carci-
noma (n = 87), malignant pleural mesothelioma (n = 5),
and intrapulmonary metastatic disease (n = 7) were
entered in the study. Fourteen patients were excluded
from the study due to protocol violation (n = 5) and
technically inadequate VRI recordings (n = 9).
Evaluable data from 85 patients were included in the
analysis. Baseline patients’ characteristics are shown in
Table 1. At time of data analysis, lung resections and post-
operative pulmonary function tests had been obtained on
31 of these patients. Comparative analyses of predicted
versus actual postoperative lung function measurements
were based on 4 pneumonectomy and 27 lobectomy
procedures.
Agreement between VRI and radionuclide studies for
determining the projected percentage loss of lung
function
Bland-Altman plots were used to calculate the agree-
ment between the projected percentage loss of lung
function for pneumonectomy (Figure 2) and lobectomy
(Figure 3) estimated by VRI and radionuclide perfusion
and ventilation tests. The limits of agreement are shown
as two horizontal lines; the closer the lines are together,
the better the agreement. The limits of agreement and
mean difference are shown in Table 2 for each compari-
son. Agreement between radionuclide ventilation and
perfusion was better than agreement between VRI and
radionuclide perfusion (p < 0.0001).
Agreement between ppoFEV1% as calculated by VRI
and radionuclide perfusion and ventilation could not be
performed, since these projections always used the same
baseline preoperative FEV1% in their calculation (see
methods, formula 1). This violates one of the fundamen-
tal assumptions of the Bland Altman method requiring
that the two measures be independently taken. The
same applies to agreement of ppoDLCO%.
Clinical concordance between VRI and radionuclide
studies
Since patients with ppoFEV1% and ppoDLCO% > 40%
as predicted by perfusion studies are considered eligible
for resection without need for further testing [1,12], we
defined ppoFEV1% and ppoDLCO% values greater than
or equal to 40% as positive (eligible for resection) and
Table 1 Baseline characteristics
Values Variable
n = 85 All eligible patients
65 ± 8 yrs (range 47-83) Age
M/F = 45/40 Gender
Diagnosis
74 Non-small cell lung cancer
4 Malignant pleural mesothelioma
7 Metastatic disease to lung
Baseline pulmonary function
79 ± 8 FEV1%
74 ± 22 DLCO%*
Type of surgery performed**
6 Pneumonectomy
40 Lobectomy
*DLCO results were available on only 84 patients. **Postoperative pulmonary
function was available on only 31 patients (4 pneumonectomies, 27
lobectomies).
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Figure 2 Bland Altman plot for agreement of different
technologies when calculating projected percentage of lung
function loss with pneumonectomy. (Top) Comparison of
perfusion scintigraphy and VRI. (Middle) Comparison of ventilation
scintigraphy and VRI. (Bottom) Comparison of perfusion scintigraphy
and ventilation scintigraphy. Top and bottom horizontal lines
represent limits of agreement; middle horizontal line is the mean
difference.
Figure 3 Bland Altman plot for agreement of different
technologies when calculating projected percentage of lung
function loss with lobectomy. (Top) Comparison of perfusion
scintigraphy and VRI. (Middle) Comparison of ventilation
scintigraphy and VRI. (Bottom) Comparison of perfusion scintigraphy
and ventilation scintigraphy. Top and bottom horizontal lines
represent limits of agreement; middle horizontal line is the mean
difference.
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values below 40% as negative (further assessment
needed). We defined clinical concordance for different
testing methods (VRI, perfusion scintigraphy) as both
methods agreeing that a patient either was eligible for
resection (≥40%) or needed to undergo further assess-
ment (< 40%). The clinical concordance for predictions
using VRI compared to predictions with perfusion scin-
tigraphy for ppoFEV1% and ppoDLCO% > 40% was 73%
for possible pneumonectomy and 93% for possible
lobectomy (Figure 4).
Diagnostic test ability to explain variation in
postoperative FEV1% and DLCO%
Analyses of preoperative projections versus actual post-
operative measurements are based on extent of surgery
performed (4 pneumonectomy procedures and 27 lobect-
omy procedures) from 31 subjects who had surgery and
postoperative lung function testing. The ppoFEV1%
values calculated by VRI versus actual measurements of
postoperative FEV1% are shown in Figure 5A. A similar
comparison based on perfusion scintigraphy is shown in
Figure 5B.
We further explored the ability of VRI, radionuclide
perfusion and ventilation to explain variability in FEV1%
measured postoperatively using multivariable models
(Table 3). We used the adjusted R2 as a measure of the
proportion of the variability explained by the test. As
expected, knowledge of baseline preoperative FEV1% was
useful in explaining variation in FEV1% measured post-
operatively (adjusted R2 = 0.19). Estimating residual func-
tional lung using perfusion scans, in the absence of
knowing the baseline FEV1%, was not useful (adjusted R
2
= 0.02). Combining information of residual functional
lung from perfusion scans with information about base-
line FEV1% improved ability to explain variations in
FEV1% measured postoperatively as compared to know-
ing just the baseline FEV1%. (p-value for the interaction
term 0.02).
We performed the same analysis for VRI. Again,
knowledge of residual functional lung, in the absence of
Table 2 Agreement between methods for determining percentage of lung function lost
Mean Difference
(95% CI)
Limits of Agreement Comparison
Pneumonectomy
2.38% (-4.69% to -0.07%) -23.79% to 19.04% Perfusion scintigraphy and VRI
-2.42% (-4.49% to -0.35%) -21.61% to 16.78% Ventilation scintigraphy and VRI
0.04% (-1.12% to 1.20%) -10.72% to 10.79% Perfusion and ventilation scintigraphy
Lobectomy
-0.70% (CI -2.51% to 1.12%) -16.47% to 15.08% Perfusion scintigraphy and VRI
-0.86% (CI -2.45% to 0.73%) -14.68% to 12.96% Ventilation scintigraphy and VRI
0.16% (CI -1.02% to 1.34%) -10.08% to 10.40% Perfusion and ventilation scintigraphy
Figure 4 Clinical concordance for predictions using VRI compared to predictions with perfusion scintigraphy for ppoFEV1% and
ppoDLCO% > 40%.
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information about baseline FEV1%, was not useful. How-
ever, combining information of residual functional lung
from VRI with information about baseline FEV1% did
not significantly improve the ability to explain variations
in measured postoperative FEV1% as compared to know-
ing just the baseline FEV1%.
The ability of radionuclide perfusion testing to explain
variability in actual measured postoperative FEV1% was
better than VRI, but the difference failed to reach statis-
tical significance (adjusted R2 0.32 for perfusion versus
0.20 for VRI; p = 0.32).
Agreement between projected versus measured values of
postoperative FEV1% and DLCO%
Agreement between ppoFEV1% and measured post-
operative FEV1% and DLCO% was assessed by the
Bland-Altman method and shown in Figures 6 and 7.
The limits of agreement and mean differences are
given in Table 4. The agreement between measured
postoperative FEV1% and ppoFEV1% using perfusion
scintigraphy was not significantly different than the
agreement between measured postoperative FEV1%
and ppoFEV1% using VRI (p = 0.54). Similarly, the
agreement between measured postoperative DLCO%
and ppoDLCO% using perfusion scanning was not
significantly different than the agreement between
measured postoperative DLCO% and ppoDLCO%
using VRI (p = 0.11).
Discussion
Our study describes the potential use of vibration
response imaging (VRI) as a simpler alternative to lung
scintigraphy for prediction of postoperative lung func-
tion in patients with intrathoracic malignancies. The
question is whether the agreement between VRI and
perfusion and between VRI and actual postoperative
values is sufficient to consider using VRI in clinical
practice. In this pilot study, we were able to obtain esti-
mates of the limits of agreement between methods
when calculating projected percentage of lung function
Figure 5 Projected postoperative FEV1% compared to actual measurements. (A) Projections based on VRI. (B) Projections based on
radionuclide perfusion scans. Dotted line is the line of unity, indicating perfect agreement. Solid line is the regression line for least-squares fit.
Table 3 Model fit as measured by adjusted R2 for different test methods
Testing Method
ModelsVRI Ventilation Perfusion
0.19 0.19 0.19 Baseline FEV1%
-0.02 -0.02 0.02 Residual functional lung determined by test method
Baseline FEV1% +
0.22 0.26 0.28 Residual functional lung determined by test method +
(Baseline FEV1% × Residual functional lung by test method)
0.20 0.22 0.32 Baseline FEV1% × Residual functional lung by test method
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lost. There was less agreement between VRI and perfu-
sion than there was between ventilation and perfusion.
To put this into context, when answering the question
of surgical resectability, clinical concordance between
VRI and perfusion was 73% for pneumonectomy and
93% for lobectomy. However, when comparing projected
values to actual postoperative values, we failed to
demonstrate a significant difference between VRI, perfu-
sion, and ventilation. Yet, perfusion was able to explain
more of the variability observed in postoperative FEV1%
than VRI.
Many investigators have used the product-moment
correlation coefficient (r) as an indicator of agreement.
However, that is incorrect, since r measures the strength
of a relation between variables but not agreement [13].
For example the series 2, 3, 4, 5, and 6 correlates well
with the series 20, 30, 40, 50, and 60 but certainly they
do not agree. It has been known for some time that a
ppoFEV1% < 40% is an indicator of increased surgical
risk [16,17]. For a new test to have clinical utility in pre-
dicting surgical risk, it is agreement with the existing
standard, not correlation that is important. We com-
pared agreement between techniques in terms of their
projected percentage loss of lung function loss rather
than ppoFEV1% or ppoDLCO%. It would have been
incorrect to evaluate agreement between techniques in
terms of their ppoFEV1% or ppoDLCO% using the
Bland-Altman method. While this has been done by
other investigators, it violates one of the key assump-
tions of the Bland Altman method, independence of
Figure 6 Agreement between projected FEV1% and actually measured postoperative FEV1% for (A) perfusion and (B) VRI, as assessed
by the Bland-Altman method. Top and bottom horizontal lines represent limits of agreement; middle horizontal line is the mean difference.
Figure 7 Agreement between projected DLCO% and actually measured postoperative DLCO% for (A) perfusion and (B) VRI, as
assessed by the Bland-Altman method. Top and bottom horizontal lines represent limits of agreement; middle horizontal line is the mean
difference.
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measures, since all techniques are calculated values that
share a common baseline number in the formula (either
FEV1% or DLCO%).
We must emphasize that VRI measures acoustic
energy, not lung perfusion or ventilation. While the
mathematics of the calculation to arrive at projected
percentage loss of lung function using VRI is analogous
to quantitative lung scintigraphy, the physical properties
being measured are distinctly different. The same could
be said when comparing perfusion and ventilation - the
mathematics is similar but the factors being measured
are distinct. Hence, the proper term for comparison is
not the calculated value of FEV1% or DLCO%, but the
percentage of lung function lost as determined by vibra-
tion energy, perfusion, or ventilation.
In addition to measures of agreement, we were able to
obtain further insights by performing longitudinal follow-
ing up. We failed to demonstrate a significant difference
between techniques in terms of their ability to estimate
the actual observed postoperative FEV1% and DLCO%.
We were able to demonstrate that combining informa-
tion from perfusion scans with information about base-
line FEV1% improved ability to explain variations in
measured postoperative FEV1% as compared to knowing
just the baseline FEV1% (p = 0.02). In contrast, we failed
to demonstrate this for VRI and ventilation, although this
may have been a function of the small sample size.
Clearly, a VRI study is simpler than other methods
that have been used for estimation of postoperative lung
function [18-21]. VRI testing can be performed by a
trained technician and does not require administration
of intravenous, inhaled, or external radiation. In spite of
its relative simplicity, appropriate technical procedures
are crucial. Recording artifacts arising from ambient
noise or increased airway secretions should be avoided.
Skin conditions or chest deformities may also interfere
with the position and adhesion of sensors to the chest
wall. During testing, attention should be placed to the
quality, amplitude, and reproducibility of recordings.
Interpretation of tests results must also consider clinical
and radiographic correlations. Causes of discrepant
results should be explored and an alternative method of
testing should be considered in some cases.
Conclusions
VRI technique would have the advantage of reducing
overall costs in the process of preoperative evaluation
and providing a non-invasive, complementary tool to
pulmonary function testing within the scope of practice
of the pulmonary technologist and the chest physician.
However, additional studies are needed to determine if
quantitative VRI could replace the radionuclide study.
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